GENEVA, Dec. 16 -- WAKUNAGA PHARMACEUTICAL CO., LTD. (5-36, Miyahara 4-chome, Yodogawa-ku, Osaka-shi, Osaka5320003), 湧永製薬株式会社 (大阪府大阪市淀川区宮原４丁目５番３６号) filed a patent application (PCT/JP2025/020274) for "SCREENING METHOD FOR TGF-Beta SIGNAL INHIBITOR OR ANTI-FIBROTIC AGENT" on Jun 04, 2025. With publication no. WO/2025/254160, the details related to the patent application was published on Dec 11, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property ...